Price movement over the last 24 hours
ACADIA Pharmaceuticals Inc. vs Paycom Software Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Paycom Software Inc trades at $138.33 (market cap $6.70B). The key difference: Paycom Software Inc is the larger of the two by market cap, and Paycom Software Inc pays a 1.04% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | PAYC | |
|---|---|---|
Market Cap | $4.49B | $6.70B |
Sector | Health | Technology |
52-Week High | $28.06 | $238.80 |
52-Week Low | $20.06 | $113.59 |
Enterprise Value | $3.69B | $7.31B |
Dividend Yield | — | 1.04% |
Trailing returns across standard periods
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →